For: | Monma T, Iwamoto J, Ueda H, Tamamushi M, Kakizaki F, Konishi N, Yara S, Miyazaki T, Hirayama T, Ikegami T, Honda A. Evaluation of gut dysbiosis using serum and fecal bile acid profiles. World J Clin Cases 2022; 10(34): 12484-12493 [PMID: 36579096 DOI: 10.12998/wjcc.v10.i34.12484] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i34/12484.htm |
Number | Citing Articles |
1 |
Ke Chen, Huafeng Geng, Cong Ye, Junbao Liu, Yunhe Fu. Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome. Microbiology Spectrum 2024; 12(8) doi: 10.1128/spectrum.04291-23
|
2 |
Yueyue Ma, Haoze Yang, Xiaoming Wang, Yuhong Huang, Yuhong Li, Guixiang Pan. Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies. Journal of Ethnopharmacology 2025; 337: 118968 doi: 10.1016/j.jep.2024.118968
|
3 |
Run-Hao Xu, Jia-Nan Shen, Jing-Bo Lu, Yi-Jing Liu, Yan Song, Yun Cao, Zhen-Huan Wang, Jie Zhang. Bile acid profiles and classification model accuracy for inflammatory bowel disease diagnosis. Medicine 2024; 103(23): e38457 doi: 10.1097/MD.0000000000038457
|
4 |
Javier Mateu-Fabregat, Hamza Mostafa, Raul Sanchez-Gimenez, Óscar M. Peiró, Gil Bonet, Anna Carrasquer, Georgios A. Fragkiadakis, Alfredo Bardaji, Mònica Bulló, Christopher Papandreou. Bile Acids and Risk of Adverse Cardiovascular Events and All-Cause Mortality in Patients with Acute Coronary Syndrome. Nutrients 2024; 16(7): 1062 doi: 10.3390/nu16071062
|